[Delay in diabetic late complications--a biological activity of insulin-C-peptide?].
Gallwitz
B
B
I. Medizinische Klinik, Christian-Albrechts-Universität Kiel.
Schmidt
W E
WE
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002199:Capillary Permeability / Q000502:physiology; D003921:Diabetes Mellitus, Experimental / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D003925:Diabetic Angiopathies / Q000503:physiopathology / Q000517:prevention & control; D003928:Diabetic Nephropathies / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D010455:Peptides / Q000008:administration & dosage / Q000502:physiology*; D051381:Rats
D001786:Blood Glucose; D010455:Peptides; C050632:polypeptide C
Verzögerung von Diabetes-Spätkomplikationen--eine biologische Aktivität des Insulin-C-Peptids?